Biotie To Present At The 8th Annual Rodman & Renshaw Healthcare Conference
Webcast will be available at www.biotie.com
November 1, 2006 - Biotie Therapies Corp. (OMX: BTH1V) announced today that Dr. Timo Veromaa, President and Chief Executive Officer, will be presenting at the 8th Annual Rodman & Renshaw Healthcare Conference in New York, on Monday November 6, 2006, at 09:30 a.m. local time. A webcast of the presentation will be available on the Company’s website, www.biotie.com.
Notes to editors
Biotie Therapies Corp.
BioTie is a Finnish drug development company, with a focus on dependence disorders, inflammatory diseases and thrombosis. In particular, it is a pioneer in dependence disorders and has been developing nalmefene for the treatment of alcoholism and pathological gambling since 1999. It also has novel products in development for the treatment of inflammation and thrombosis.
BioTie’s shares are listed on the Helsinki Stock Exchange, Nordic list (Small Cap, Healthcare)
- Contact Information
- Timo Veromaa
- Chief Executive Officer
- Biotie Therapies Corp.
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.